PEPID Launches Duplicate Therapy Checker
Most powerful drug interaction checker now supports duplicate therapy.
Phoenix, AZ, May 12, 2011 --(PR.com)-- PEPID, the leading provider of developer drug data and clinical decision support information and technology for healthcare systems and professionals, today announced the addition of duplicate therapy checking to its robust drug interaction checker.
“As more and more drugs come on the market with multiple uses, and off label uses become more commonplace checking for duplicate therapy between medications is crucial, and must be considered in medication administration and prescribing,” says John Wagner, PEPID President. “We are excited to offer this new functionality to our users, as we continue to offer the full spectrum of clinical decision support through the PEPID Knowledge Base.”
PEPID’s drug interaction checker provides alerts for duplicate therapy on three different levels — therapeutic class, pharmacologic class and the ingredient level — making it the most comprehensive on the market today. This is in addition to the drug-drug, drug-allergy, drug-food and drug-herbal checks already available — solidifying the company’s position as the largest and most authoritative drug database on the market.
The duplicate therapy check will allow electronic medical record or pharmacy information systems to give users a warning if a duplicate therapy exists. This functionality helps to meet the requirements for meaningful use reimbursements.
“Our enhanced drug interaction checker functions allows system developers to use our software development kit to easily create customized alerts for duplicate therapy, drug allergy reactions and drug interactions,” says Edward Reynolds, PEPID chief technology officer. “Our drug interaction methods can be implemented with about 10 lines of code, which greatly reduces development time so EMR providers can release this critical functionality quickly.”
System developers can use the PEPID software development kit and APIs to programmatically receive critical drug information monographs, dosing calculators, drug interaction, drug-allergy or duplicate therapy information.
PEPID’s reputable clinical and pharmacological content is designed to support clinicians through every stage of the decision support process, increasing safety and accuracy through better-informed patient care, and this latest module adds to the robust content and tools available, and helps to meet meaningful use criteria in electronic medical records (EMR) systems.
Learn more at pepid.com.
###
“As more and more drugs come on the market with multiple uses, and off label uses become more commonplace checking for duplicate therapy between medications is crucial, and must be considered in medication administration and prescribing,” says John Wagner, PEPID President. “We are excited to offer this new functionality to our users, as we continue to offer the full spectrum of clinical decision support through the PEPID Knowledge Base.”
PEPID’s drug interaction checker provides alerts for duplicate therapy on three different levels — therapeutic class, pharmacologic class and the ingredient level — making it the most comprehensive on the market today. This is in addition to the drug-drug, drug-allergy, drug-food and drug-herbal checks already available — solidifying the company’s position as the largest and most authoritative drug database on the market.
The duplicate therapy check will allow electronic medical record or pharmacy information systems to give users a warning if a duplicate therapy exists. This functionality helps to meet the requirements for meaningful use reimbursements.
“Our enhanced drug interaction checker functions allows system developers to use our software development kit to easily create customized alerts for duplicate therapy, drug allergy reactions and drug interactions,” says Edward Reynolds, PEPID chief technology officer. “Our drug interaction methods can be implemented with about 10 lines of code, which greatly reduces development time so EMR providers can release this critical functionality quickly.”
System developers can use the PEPID software development kit and APIs to programmatically receive critical drug information monographs, dosing calculators, drug interaction, drug-allergy or duplicate therapy information.
PEPID’s reputable clinical and pharmacological content is designed to support clinicians through every stage of the decision support process, increasing safety and accuracy through better-informed patient care, and this latest module adds to the robust content and tools available, and helps to meet meaningful use criteria in electronic medical records (EMR) systems.
Learn more at pepid.com.
###
Contact
PEPID LLC.
Jenna Reynolds
847-491-9100 x211
www.pepid.com
Jenna Reynolds
847-491-9100 x211
www.pepid.com
Contact
Categories